IBD Genomic Medicine Consortium

A Brief History: The iGenoMed Consortium was created in 2012 to take full advantage of existing and emerging genomic technologies and apply these to powerful retrospective and prospective cohorts to better understand the biological differences between patients with IBD and to develop precision medicine approaches to improve diagnosis and treatment of IBD, and to advanceContinue reading “IBD Genomic Medicine Consortium”

Quebec IBD Genetics Consortium

(1996-2017) Brief History. The Quebec IBD Genetics Consortium (QIGC) has its origins (1996-2002) in a group of five academic clinical centers that collected DNA samples and clinical information for IBD genetics projects.  In 2002, it played an integral part in the creation of the North American IBD Genetics Consortium (IBDGC), which was constituted by six different centersContinue reading “Quebec IBD Genetics Consortium”